1Denhardt DT,Giachelli CM,Rittling SR,et al.Role of osteopontin in cellular signaling and toxicant injury[J].Annu Rev Pharmacol Toxicol,2001;41:723-749
2Wang D,Yamamoto S,Hijiya N,et al.Transcriptional regulation of the human osteopontin promoter:functional analysis and DNA 2 protein interactions[J].Oncogene,2000; 19(50):5801-5809
3Denhardt DT,Giachelli CM,Rittling SR.Role of osteopontin incellular signaling and toxicant injury[J].Annu Rev Pharmacol Toxi 2col,2001 ;41:723-749
4Oates AJ,Barraclough R,Rudl PS,et al.The identification of osteo 2 pontin as a metastasis 2 related gene product in a rodent mammary tumour model[J].Oncogene,1996;13:97-104
5Urquidi V,Sloan D,Kawai K,et al.Contrasting expression of thrombospondin 21 and osteopontin correlates with absence or pres 2 ence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis[J].Clin Cancer Res,2002;8:61-74
6Denhardt DT,Mistretta D,Chambers AF,et al.Transcriptional regu2 lation of osteopontin and the metastatic phenotype:evidence for a ras 2 activated enhancer in the human open promoter[J].Clin Exp Metastasis,2003;20(1):77-84
7Shijube N,Uede T,Kon S,et al.Vascular endothelial growth factor and osteopontin in tumor biology[J].Crit Rev Oncog,2000; 11 (2):135-146
3[1]Oldberg A, Franzen A, Heiregard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA, 1986, 83(23):8 819-23.
4[2]Meerwitch K, Bergeron F, Leblond L, et al. A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type Ⅰ collagen. Vascu Pharm, 2003, 40:77-89.
5[3]Cooper CR, Chay CH, Pienta KJ. The role of alpha(v)beta(3) in prostate cancer progression. Noplasia, 2002, 4(3):191-4.
6[4]Hotte SJ, Winquist EW, Stitt L, et al. Plasma osteopontin associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. Cancer, 2002, 95(3): 506-12.
7[5]Tuck AB, Hota C, Wilson SM, et al. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene, 2003, 22(8):1 198-205.
8[6]Adler B, Ashkar S, Cantor H, et al. Stimulation through adhesion molecules determines the response to ligation of the T-cell antigen receptor. Cell Immunol, 2001, 210:30-40.
9[7]Denhardt DT, Giachelli CM, Rittling SR. Role of Osteopontin cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol, 2001, 41:723-49.
10[8]Philip S, Kundu GC. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem, 2003, 278(16):14 487-97.
4Hildebrandt B, Wust P, Gellermann J, et al. Treatment of locally recurrent rectal cancer with special focus on regional pelvic hyperthermia[ J]. Onkologie ,2004, 27 (5) :506-511.
5Kwok SP, Lau WY, Leung KL, et al. Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma [ J ]. Sr J Surg, 1996,83 (7) :969-972.
6Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis[ J ]. Semin Ultrasound CT MR,2005, 26(4) :259-268.
7Gangopadhyay A, Lazure DA, Thomas P. Adhesion of coloreetal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells [ J ]. Clin Exp Metastasis, 1998,16 (8) :703-712.
8Braakhuis BJ, Brakenhoff RH, Leemans CR. Second field tumors: a new opportunity for cancer prevention [ J ]. Oncologist,2005,10 (7) : 493 -500.
9Gonzalez-Aguilera JJ, Oliart S, Azcoita MM, et al. Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer[ J]. Am J Clin Oncol,2004,27( 1 ) :39-45.
